Preferred Language
Articles
/
wxdbOI8BVTCNdQwCdWPo
The most ABO blood group susceptibility to COVID-19 infections in Baghdad city
...Show More Authors

Scopus Crossref
View Publication
Publication Date
Wed Jan 12 2022
Journal Name
Iraqi Journal Of Pharmaceutical Sciences ( P-issn 1683 - 3597 E-issn 2521 - 3512)
A Pharmacoeconomics Study for Anticoagulants used for Hospitalized COVID-19 Patients in Al-Najaf Al-Ashraf city –Iraq(Conference Paper )#
...Show More Authors

Abstract

Background: The novel coronavirus 2 (SARS?CoV?2) pandemic is a pulmonary disease, which leads to cardiac, hematologic, and renal complications. Anticoagulants are used for COVID-19 infected patients because the infection increases the risk of thrombosis. The world health organization (WHO), recommend prophylaxis dose of anticoagulants: (Enoxaparin or unfractionated Heparin for hospitalized patients with COVID-19 disease. This has created an urgent need to identify effective medications for COVID-19 prevention and treatment. The value of COVID-19 treatments is affected by cost-effectiveness analysis (CEA) to inform relative value and how to best maximize social welfare through eviden

... Show More
View Publication Preview PDF
Scopus (5)
Crossref (3)
Scopus Crossref
Publication Date
Wed Jan 12 2022
Journal Name
Iraqi Journal Of Pharmaceutical Sciences ( P-issn: 1683 - 3597 , E-issn : 2521 - 3512)
A Pharmacoeconomics Study for Anticoagulants used for Hospitalized COVID-19 Patients in Al-Najaf Al-Ashraf city –Iraq(Conference Paper )#
...Show More Authors

Abstract Background: The novel coronavirus 2 (SARS?CoV?2) pandemic is a pulmonary disease, which leads to cardiac, hematologic, and renal complications. Anticoagulants are used for COVID-19 infected patients because the infection increases the risk of thrombosis. The world health organization (WHO), recommend prophylaxis dose of anticoagulants: (Enoxaparin or unfractionated Heparin for hospitalized patients with COVID-19 disease. This has created an urgent need to identify effective medications for COVID-19 prevention and treatment. The value of COVID-19 treatments is affected by cost-effectiveness analysis (CEA) to inform relative value and how to best maximize social welfare through evidence-based pricing decisions. O

... Show More
Scopus (5)
Crossref (3)
Scopus Crossref
Publication Date
Thu Sep 16 2021
Journal Name
International Journal Of Clinical Practice
An overview of post‐COVID‐19 complications
...Show More Authors

View Publication
Scopus (4)
Crossref (6)
Scopus Crossref
Publication Date
Fri Jan 27 2023
Journal Name
Research Journal Of Pharmacy And Technology
Physical human Activity, Immunity and COVID-19
...Show More Authors

Background: The global threat of COVID-19 outbreak and on the 11 March 2020, WHO acknowledged that the virus would likely spread to all countries across the globe and declared the coronavirus outbreak a pandemic which is the fifth pandemic since 20 century and this has brought human lives to a sudden and complete lockdown and the confirmed cases of this disease and deaths continue to rise in spite of people around the world are taking important actions to mitigate and decrease transmission and save lives. Objectives: To assess the effect of exercise and physical activity on the immunity against COVID-19. Methods: Collected electronic databases including (Medline, EMBASE, Google Scholar, PubMed and Web of Science) were searched with

... Show More
View Publication
Scopus (1)
Crossref (1)
Scopus Crossref
Publication Date
Tue Nov 16 2021
Journal Name
Journal Of Clinical Laboratory Analysis
Hematological changes associated with COVID‐19 infection
...Show More Authors
Abstract<sec><title>Background

The unresolved COVID‐19 pandemic considerably impacts the health services in Iraq and worldwide. Consecutive waves of mutated virus increased virus spread and further constrained health systems. Although molecular identification of the virus by polymerase chain reaction is the only recommended method in diagnosing COVID‐19 infection, radiological, biochemical, and hematological studies are substantially important in risk stratification, patient follow‐up, and outcome prediction.

Aim

This narrative review summarized the hematological changes including the blood indices, coagulative indicator

... Show More
View Publication
Scopus (35)
Crossref (38)
Scopus Clarivate Crossref
Publication Date
Fri Dec 01 2023
Journal Name
Slas Discovery
Role Of Vaccines Against COVID-19 Pandemic
...Show More Authors

View Publication
Scopus (2)
Crossref (3)
Scopus Clarivate Crossref
Publication Date
Tue Jun 01 2021
Journal Name
Int. J. Nonlinear Anal. Appl.
Time series analysis of the number of covid-19 deaths in Iraq
...Show More Authors

Preview PDF
Scopus (1)
Scopus
Publication Date
Sun Jan 01 2023
Journal Name
2nd International Conference Of Mathematics, Applied Sciences, Information And Communication Technology
Spatial and temporal analysis of the spread of Covid-19 in Iraq
...Show More Authors

View Publication
Scopus Crossref
Publication Date
Tue Oct 01 2024
Journal Name
International Immunopharmacology
mRNA vaccination reduces the thrombotic possibility in COVID-19: Inflammation risk estimates
...Show More Authors

Thrombosis is a common clinical feature associated with morbidity and mortality in coronavirus disease-2019 (COVID-19) patients. Cytokine storm in COVID-19 increases patients' systemic inflammation, which can cause multiple health consequences. In this work, we aimed to indicate the effect of Pfizer-BioNTech vaccination on the modulation of monocyte chemoattractant protein-3 (MCP-3), matrix metalloproteinase 1 (MMP-1), and tumor necrosis factor-alpha (TNF-α) levels, and other systemic inflammatory biomarkers that associates with COVID-19 severity in patients who suffers from thrombosis consequences. For this purpose, ninety people were collected from Ibn Al-Nafees Hospital and divided into three groups each of which contained 30 people, 15

... Show More
View Publication
Scopus Clarivate Crossref
Publication Date
Tue May 30 2023
Journal Name
Iraqi Journal Of Science
Deep Convolutional Neural Network Architecture to Detect COVID-19 from Chest X-Ray Images
...Show More Authors

      Today, the world is living in a time of epidemic diseases that spread unnaturally and infect and kill millions of people worldwide. The COVID-19 virus, which is one of the most well-known epidemic diseases currently spreading, has killed more than six million people as of May 2022. The World Health Organization (WHO) declared the 2019 coronavirus disease (COVID-19) after an outbreak of SARS-CoV-2 infection. COVID-19 is a severe and potentially fatal respiratory disease caused by the SARS-CoV-2 virus, which was first noticed at the end of 2019 in Wuhan city. Artificial intelligence plays a meaningful role in analyzing medical images and giving accurate results that serve healthcare workers, especially X-ray images, which are co

... Show More
View Publication Preview PDF
Scopus (5)
Crossref (6)
Scopus Crossref